在多发性骨髓瘤进展中,METTL3/MALAT1轴的调控作用
Xiaohong Lu1, Yafei Li1, Ruie Li1
1Department of Oncology, Luzhou People's Hospital, Luzhou 646000 Sichuan Province, China.
Journal of bone oncology
|July 17, 2025
概括
甲基转移酶类3 (METTL3) 通过增加MALAT1表达来增强多发性骨髓瘤 (MM) 的发展. 向METTL3或MALAT1可以抑制MM患者的癌细胞生长和恶性瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 甲基转移酶类3 (METTL3) 通过m6A依赖和独立的机制与癌症进展有关.
- 长非编码RNA转移相关的肺腺癌转录1 (MALAT1) 也参与瘤发生.
研究的目的:
- 研究METTL3和MALAT1在多发性骨髓瘤 (MM) 发病过程中的作用.
- 阐明MM中METTL3和MALAT1之间的相互作用和机制.
主要方法:
- 从56名MM患者和42名健康捐赠者的骨髓样本中评估了METTL3和MALAT1水平.
- 在RPMI8226和U266MM细胞系中利用了与METTL3和MALAT1相关的寡核酸的细胞转染.
- 评估了对细胞亡,迁移,增殖和入侵的影响.
主要成果:
- 在MM患者中,METTL3和MALAT1水平显著升高.
- 与METTL3或MALAT1表达的干扰抑制了MM细胞的恶性行为.
- 证实了METTL3和MALAT1之间的相互作用,MALAT1的过度表达抵消了METTL3干扰效应.
结论:
- METTL3通过上调MALAT1表达来促进MM的发展.
- METTL3-MALAT1轴代表了多发性骨髓瘤的潜在治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K


